Kymera Therapeutics (KYMR) PT Raised to $150 at Citi

October 5, 2026 5:03 AM

Citi analyst Geoff Meacham raised the price target on Kymera Therapeutics (NASDAQ: KYMR) to $150.00 (from $135.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found